SURVIVAL AND DESFERRIOXAMINE IN THALASSEMIA MAJOR

被引：207

作者：

MODELL, B

LETSKY, EA

FLYNN, DM

PETO, R

WEATHERALL, DJ

机构：

[1] HOSP SICK CHILDREN,LONDON WC1N 3JH,ENGLAND

[2] ROYAL FREE HOSP,LONDON NW3 2QG,ENGLAND

[3] RADCLIFFE INFIRM,NUFFIELD DEPT CLIN MED,CLIN TRIAL SERV UNIT,OXFORD OX2 6HE,ENGLAND

[4] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND

来源：

BRITISH MEDICAL JOURNAL | 1982年 / 284卷 / 6322期

关键词：

D O I：

10.1136/bmj.284.6322.1081

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：1081 / 1084

页数：4

相关论文

共 15 条

[1] LONG-TERM CHELATION THERAPY IN THALASSEMIA MAJOR - EFFECT ON LIVER IRON CONCENTRATION, LIVER HISTOLOGY, AND CLINICAL PROGRESS
BARRY, M
FLYNN, DM
LETSKY, EA
RISDON, RA
[J]. BMJ-BRITISH MEDICAL JOURNAL, 1974, 2 (5909): : 16 - 20
[2] ECHOCARDIOGRAPHIC ABNORMALITIES IN PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA AND SECONDARY MYOCARDIAL IRON DEPOSITION
HENRY, WL
NIENHUIS, AW
WIENER, M
MILLER, DR
CANALE, VC
PIOMELLI, S
[J]. AMERICAN JOURNAL OF MEDICINE, 1978, 64 (04) : 547 - 555
[3] HOFFBRAND AV, 1979, LANCET, V1, P947
[4] HUSSAIN MAM, 1976, LANCET, V2, P1278
[5] CARDIAC-ARRHYTHMIAS IN THALASSEMIA MAJOR - EVALUATION OF CHELATION TREATMENT USING AMBULATORY MONITORING
KAYE, SB
OWEN, M
[J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6109) : 342 - 342
[6] Letsky E A, 1976, Birth Defects Orig Artic Ser, V12, P31
[7] Modell B, 1979, Prog Hematol, V11, P267
[8] LONG-TERM DESFERRIOXAMINE THERAPY IN THALASSEMIA
MODELL, CB
BECK, J
[J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 232 (MAY24) : 201 - 210
[9] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES
PETO, R
PIKE, MC
ARMITAGE, P
BRESLOW, NE
COX, DR
HOWARD, SV
MANTEL, N
MCPHERSON, K
PETO, J
SMITH, PG
[J]. BRITISH JOURNAL OF CANCER, 1977, 35 (01) : 1 - 39
[10] PIPPARD MJ, 1978, LANCET, V1, P1178